Hypera S.A. logo

Hypera S.A. (HYPE3)

Market Closed
12 Jun, 19:55
B3 B3
R$
21. 37
+0.11
+0.5174%
R$
13.08B Market Cap
11.13 P/E Ratio
0.09% Div Yield
1.63M Volume
0 Eps
R$ 21.26
Previous Close
Add Transaction
Day Range
20.95 21.58
Year Range
20.55 28.87
Want to track HYPE3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HYPE3 closed today higher at R$21.37, an increase of 0.5174% from yesterday's close, completing a monthly decrease of -4.8531% or -R$1.09. Over the past 12 months, HYPE3 stock lost -9.2954%.
HYPE3 pays dividends to its shareholders, with the most recent payment made on Dec 31, 2025. The next announced payment will be in In 5 months on Dec 01, 2026 for a total of R$0.2925.
The last earnings report, released on Apr 21, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.2233%, based on the last three reports.
Hypera S.A. has completed 1 stock splits, with the recent split occurring on Jan 04, 2010.
The company's stock is traded on one exchange.

HYPE3 Chart

People also search for

Stride Inc. Depositary Receipt
R$ 125.68
+1.2242%
Iron Mountain Incorporated - BDR
R$ 644.16
0%
Keysight Technologies Inc. BDR
R$ 889.14
+3.6995%
Tapestry Inc.
R$ 695.8
0%
Honda Motor Co., Ltd.
R$ 134.12
-2.444%

Hypera S.A. (HYPE3) FAQ

What is the stock price today?

The current price is R$21.37.

On which exchange is it traded?

Hypera S.A. is listed on B3.

What is its stock symbol?

The ticker symbol is HYPE3.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.09%.

What is its market cap?

As of today, the market cap is 13.08B.

Has Hypera S.A. ever had a stock split?

Hypera S.A. had 1 splits and the recent split was on Jan 04, 2010.

Hypera S.A. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Breno Toledo Pires de Oliveira CEO
B3 Exchange
BRHYPEACNOR0 ISIN
BR Country
10,481 Employees
1 Apr 2026 Last Dividend
4 Jan 2010 Last Split
- IPO Date

Overview

Hypera S.A. is a prominent pharmaceutical company based in Brazil, known for its expansive portfolio of healthcare products. Initially established in 2001 under the name Hypermarcas S.A., the company underwent a name change to Hypera S.A. in February 2018, signifying a new era in its history. Operating primarily within Brazil, Hypera S.A. specializes in developing, producing, and marketing a wide range of pharmaceutical products, including prescription medications, over-the-counter (OTC) drugs, and nutritional supplements. Its mission centers on delivering high-quality healthcare solutions to improve the well-being of its consumer base. Headquartered in São Paulo, Brazil, Hypera S.A. stands as a leading entity in the Latin American pharmaceutical landscape.

Products and Services

Hypera S.A. offers an extensive variety of products and services categorized into several segments: pharmaceuticals, consumer health products, and nutritional and vitamin supplements. Listed below are some of the company's notable products and brands:

  • Pharmaceutical Products: The company's strong pharmaceutical portfolio includes prescription medications like Adacne, Addera, Celestamine, and Diprosone among others, catering to various healthcare needs from dermatological solutions to anti-inflammatory agents. They also offer a range of products such as Deciprax, Emprol XR, and Max Sulid, focusing on providing comprehensive healthcare remedies.
  • Sun Protection and Skincare: Under the Mantecorp Skincare brand, Hypera S.A. provides a spectrum of sun protection and moisturizing skin care products, addressing the growing consumer needs for comprehensive dermatological care and protection against harmful UV rays.
  • Consumer Health Products: The company's consumer health sector is symbolized by household names like Apracur, Benegrip, and Neosaldina, catering to everyday health issues such as cold and flu, digestive discomfort, and pain relief. The Neo Química brand is renowned for offering a range of similar and generic drugs, expanding the company’s reach in the consumer health market.
  • Nutritional and Vitamin Supplements: Recognizing the importance of dietary supplements in modern healthcare, Hypera S.A. markets products under the Tamarine, Vitasay, and Zero-Cal brands. These offer solutions for nutritional deficiencies and support overall health and wellness.
  • Generic Medicines: Emphasizing accessibility and affordability, Hypera S.A. provides a wide array of generic medicines including Hydroxyzine, Naproxene, and Omeprazole. This segment ensures patients have access to essential medications at lower costs while maintaining high-quality standards.

Contact Information

Address: Av. Magalhães de Castro, 4800
Phone: 55 11 3627 4206